CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy

JACC: Cardiovascular Imaging

Volumn 6, Issue 9, 2013, Pages 944-954

  Neilan, Tomas G ^a,b   Coelho Filho, Otavio R ^a   Danik, Stephan B ^b   Shah, Ravi V ^a,b   Dodson, John A ^a   Verdini, Daniel J ^b   Tokuda, Michifumi ^a   Daly, Caroline A ^a   Tedrow, Usha B ^a   Stevenson, William G ^a   Jerosch Herold, Michael ^a   Ghoshhajra, Brian B ^b   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cardiac magnetic resonance; implantable cardioverter defibrillators; late gadolinium enhancement; nonischemic cardiomyopathy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BREATH HOLDING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FULL WIDTH HALF MAXIMUM METHOD; HAZARD RATIO; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL SCAR; NONISCHEMIC CARDIOMYOPATHY; PREDICTOR VARIABLE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SCAR; SEX RATIO; SUDDEN CARDIAC DEATH; TREATMENT INDICATION;

CARDIAC MAGNETIC RESONANCE; CMR; EF; EJECTION FRACTION; FULL-WIDTH HALF-MAXIMUM; FWHM; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; LATE GADOLINIUM ENHANCEMENT; LATE GADOLINIUM ENHANCEMENT; LGE; MACE; MAJOR ADVERSE CARDIAC EVENTS; NIDC; NONISCHEMIC CARDIOMYOPATHY; NONISCHEMIC DILATED CARDIOMYOPATHY; SCD; SUDDEN CARDIAC DEATH; VENTRICULAR TACHYCARDIA; VT;

CARDIOMYOPATHY, DILATED; CICATRIX; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84883872344     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.05.013     Document Type: Article

References (31)

1. G.W. Dec, and V. Fuster Idiopathic dilated cardiomyopathy N Engl J Med 331 1994 1564 1575
2. A. Kadish, A. Dyer, and J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
3. A.S. Desai, J.C. Fang, W.H. Maisel, and K.L. Baughman Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials JAMA 292 2004 2874 2879
4. H. Ghanbari, G. Dalloul, and R. Hasan Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 1500 1506
5. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
6. W.H. Maisel, M. Moynahan, and B.D. Zuckerman Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports JAMA 295 2006 1901 1906
7. J.J. Goldberger, M.E. Cain, and S.H. Hohnloser American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Circulation 118 2008 1497 1518
8. S. Lehrke, D. Lossnitzer, and M. Schob Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy Heart 97 2011 727 732
9. R.G. Assomull, S.K. Prasad, and J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
10. K.C. Wu, R.G. Weiss, and D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
11. L. Iles, H. Pfluger, and L. Lefkovits Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
12. F.M. Bogun, B. Desjardins, and E. Good Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate J Am Coll Cardiol 53 2009 1138 1145
13. S. Nazarian, D.A. Bluemke, and A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
14. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 93 1996 841 842
15. H. Abdel-Aty, P. Boye, and A. Zagrosek Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches J Am Coll Cardiol 45 2005 1815 1822
16. L.C. Amado, B.L. Gerber, and S.N. Gupta Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model J Am Coll Cardiol 44 2004 2383 2389
17. R.J. Kim, D.S. Fieno, and T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
18. I.W. Hammond, R.B. Devereux, and M.H. Alderman The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension J Am Coll Cardiol 7 1986 639 650
19. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
20. P.R. Liebson, G. Grandits, and R. Prineas Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS) Circulation 87 1993 476 486
21. J. Cohen Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit Psychol Bull 70 1968 213 220
22. O. Zimmermann, O. Grebe, and N. Merkle Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy Eur J Heart Fail 8 2006 162 166
23. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
24. C.S. Broberg, S.S. Chugh, C. Conklin, D.J. Sahn, and M. Jerosch-Herold Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease Circ Cardiovasc Imaging 3 2010 727 734
25. A.S. Flett, M.P. Hayward, and M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
26. M.G. Friedrich, U. Sechtem, and J. Schulz-Menger Cardiovascular magnetic resonance in myocarditis: A JACC White Paper J Am Coll Cardiol 53 2009 1475 1487
27. A.S. Flett, J. Hasleton, and C. Cook Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance J Am Coll Cardiol Img 4 2011 150 156
28. D.V. Unverferth, P.B. Baker, and S.E. Swift Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy Am J Cardiol 57 1986 816 820
29. J.A. Salerno-Uriarte, G.M. De Ferrari, and C. Klersy Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study J Am Coll Cardiol 50 2007 1896 1904
30. B. Vrtovec, R. Delgado, A. Zewail, C.D. Thomas, B.M. Richartz, and B. Radovancevic Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure Circulation 107 2003 1764 1769
31. A.F. Jacobson, R. Senior, and M.D. Cerqueira Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study J Am Coll Cardiol 55 2010 2212 2221